Stocks and Investing Stocks and Investing
Fri, July 26, 2024

Joseph Stringer Reiterated (VRTX) at Hold on, Jul 26th, 2024


Published on 2024-10-28 12:50:16 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold on, Jul 26th, 2024.

Joseph has made no other calls on VRTX in the last 4 months.



There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $455 on, Thursday, July 11th, 2024
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024


These are the ratings of the 13 analyists that currently disagree with Joseph


  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, July 23rd, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $480 on, Monday, July 22nd, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $500 on, Friday, July 19th, 2024
  • Steve Chesney of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $545 on, Thursday, June 27th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
Contributing Sources